201 related articles for article (PubMed ID: 34754160)
1. Diagnostic usefulness of selected proteases and acute phase factors in patients with colorectal adenocarcinoma.
Sebzda T; Gnus J; Dziadkowiec B; Latka M; Gburek J
World J Gastroenterol; 2021 Oct; 27(39):6673-6688. PubMed ID: 34754160
[TBL] [Abstract][Full Text] [Related]
2. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J
J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serum sialic acid and carcinoembryonic antigen for the detection of early-stage colorectal cancer.
Tautu C; Pee D; Dunsmore M; Prorok JJ; Alhadeff JA
J Clin Lab Anal; 1991; 5(4):247-54. PubMed ID: 1890538
[TBL] [Abstract][Full Text] [Related]
4. Levels of soluble intercellular adhesion molecule-1 and total sialic acid in serum of patients with colorectal cancer.
Basoglu M; Yildirgan MI; Taysi S; Yilmaz I; Kiziltunc A; Balik AA; Celebi F; Atamanalp SS
J Surg Oncol; 2003 Jul; 83(3):180-4. PubMed ID: 12827689
[TBL] [Abstract][Full Text] [Related]
5. Serum sialic acid and carcinoembryonic levels in the detection and monitoring of colorectal cancer.
Verazin G; Riley WM; Gregory J; Tautu C; Prorok JJ; Alhadeff JA
Dis Colon Rectum; 1990 Feb; 33(2):139-42. PubMed ID: 2298100
[TBL] [Abstract][Full Text] [Related]
6. Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging.
Rahman MR; Sheikh SH; Lima IJ; Islam MR; Faisal M; Islam MS; Faruk MO; Jalal MT
Mymensingh Med J; 2016 Jan; 25(1):61-5. PubMed ID: 26931251
[TBL] [Abstract][Full Text] [Related]
7. Sialic acid levels in serum and tissue from colorectal cancer patients.
Feijoo C; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS
Cancer Lett; 1997 Jan; 112(2):155-60. PubMed ID: 9066722
[TBL] [Abstract][Full Text] [Related]
8. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
Talieri M; Papadopoulou S; Scorilas A; Xynopoulos D; Arnogianaki N; Plataniotis G; Yotis J; Agnanti N
Cancer Lett; 2004 Mar; 205(1):97-106. PubMed ID: 15036666
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer.
Ayude D; Páez De La Cadena M; Martínez-Zorzano VS; Fernández-Briera A; Rodríguez-Berrocal FJ
Oncology; 2003; 64(1):36-45. PubMed ID: 12457030
[TBL] [Abstract][Full Text] [Related]
11. Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer.
Painbeni T; Gamelin E; Cailleux A; Le Bouil A; Boisdron-Celle M; Daver A; Larra F; Allain P
Eur J Cancer; 1997 Nov; 33(13):2216-20. PubMed ID: 9470809
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.
Shimada R; Iinuma H; Akahane T; Horiuchi A; Watanabe T
Oncol Rep; 2012 Apr; 27(4):947-53. PubMed ID: 22267181
[TBL] [Abstract][Full Text] [Related]
13. Total and lipid-bound serum sialic acid in benign and malignant breast disease.
Romppanen J; Eskelinen M; Tikanoja S; Mononen I
Anticancer Res; 1997; 17(2B):1249-53. PubMed ID: 9137482
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of serum concentrations of intercellular adhesion molecule-1 in patients with colorectal cancer.
Kang X; Wang F; Xie JD; Cao J; Xian PZ
World J Gastroenterol; 2005 Jul; 11(27):4250-3. PubMed ID: 16015700
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer.
Zieglschmid V; Hollmann C; Mannel J; Albert W; Jaeschke-Melli S; Eckstein B; Hillemann T; Greten TF; Gross E; Böcher O
Anticancer Res; 2007; 27(4A):1823-32. PubMed ID: 17649779
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma.
Fernandes LC; Kim SB; Matos D
World J Gastroenterol; 2005 Feb; 11(5):645-8. PubMed ID: 15655814
[TBL] [Abstract][Full Text] [Related]
17. Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy.
Lechpammer M; Lukac J; Lechpammer S; Kovacević D; Loda M; Kusić Z
Int J Colorectal Dis; 2004 Mar; 19(2):114-20. PubMed ID: 14634775
[TBL] [Abstract][Full Text] [Related]
18. Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer.
Zhang H; Sun XF
Int J Oncol; 2001 Jul; 19(1):49-52. PubMed ID: 11408921
[TBL] [Abstract][Full Text] [Related]
19. Cysteine protease activities and tumor development in human colorectal carcinoma.
Sheahan K; Shuja S; Murnane MJ
Cancer Res; 1989 Jul; 49(14):3809-14. PubMed ID: 2544258
[TBL] [Abstract][Full Text] [Related]
20. Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.
Herszényi L; Farinati F; Cardin R; István G; Molnár LD; Hritz I; De Paoli M; Plebani M; Tulassay Z
BMC Cancer; 2008 Jul; 8():194. PubMed ID: 18616803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]